can't read?
Synonyms: 2-[3-(1-Carboxy-5-{3-naphthalen-2-yl-2-[(4-{[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraaza-cyclododec-1-yl)-acetylamino]-methyl}-cyclohexanecarbonyl)-amino]-propionylamino}-pentyl)-ureido]-pentanedioic acid
DKFZ-PSMA-617 - a novel theranostic PSMA inhibitor for both diagnosis and endoradiotherapy of prostate cancer.
DKFZ-PSMA-617 is an innovative and effective therapy for castrate-resistant metastatic prostate cancer patients.
Safety Information for this product is unavailable at this time.
Certificate Of Analysis
(For eg. B 1615-0108)
Other Documents
For any quries, please write to us at
62-56-6
Thiourea, ACS reagent, ≥99.0%
537-42-8
Pterostilbene, 99%
109-76-2
1,3-Diaminopropane, 99%
18194-24-6
1,2-Dimyristoyl-sn-glycero-3-phosphocholine, 99%
Our team of R&D Experts and Scientists have expertise in all areas of research of Lab Chemicals, Nano Technology, Life Science, Custom Synthesis, Chromatography, and many others.
DisclaimerThe above particulars do not release the customer from the obligation to carry out an inspection of goods received. Not for medical, household or any other uses, for lab use only, Please test before use.